Interleukin-10 in Epstein-Barr virus-associated post-transplant lymphomas

Clinical Transplantation

Volumn 13, Issue 4, 1999, Pages 305-312

  Garnier, Jeanne Luce ^a   Blanc Brunat, Nelly ^a   Vivier, Geneviève ^a   Rousset, Françoise ^b   Touraine, Jean Louis ^c  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b MERCK RESEARCH LABORATORIES   (United States)

^c NONE

Author keywords

B cell lymphomas; Cytokines; EBV latency and replication; Hodgkin's disease; Organ transplantation

Indexed keywords

INTERLEUKIN 10;

ADULT; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LYMPHOMA; MORTALITY; PRIORITY JOURNAL; SERUM; TUMOR CELL;

BURKITT LYMPHOMA; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENES, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTERLEUKIN-10; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MIDDLE AGED; PROGNOSIS; TUMOR VIRUS INFECTIONS;

EID: 0032811643     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0012.1999.130405.x     Document Type: Article

References (21)

1. REA D, FOURCADE C, LEBLOND V, ROWE M, JOAB I, EDELMAN L, BITKER MO, GANDJBAKHCH I, SUPERBIELLE C, FARCET JP. RAPHAEL M. Patterns of Epstein-Barr latent and replicative gene expression in Epstein Barr virus B-cell lymphoproliferative disorders after organ transplantation. Transplantation 1994: 58: 317.
2. DELECLUSE HJ, KREMMER E, ROUAULT JP, COUR C, BORNKAMM G, BERGER F. The expression of Epstein -Barr virus latent proteins is related to the pathological features of post-transplant lymphoproliferative disorders. Am J Pathol 1995: 146: 1113.
3. NALESNIK MA, JAFFE R, STARLZ TE, DEMETRIS AJ, PORTER K, BURNHAM JA, MAKOWKA L, HO M, LOCKER J. The pathology of post-transplant lymphoproliferative disorders occurring in the setting of cyclosporine A - prednisone immunosuppression. Am J Pathol 1988: 133: 173.
4. GARNIER JL, BERGER F, BETUEL H, VUILLAUME M, CHAPUIS-CELLIER C, BLANC-BRUNAT N, FAURE JL, DU-BERNARD JM, LENOIR G, TOURAINE JL. Epstein-Barr virus-associated lymphoproliferative diseases (B-cell lymphoma) after transplantation. Nephrol Dial Transplant 1989: 4: 818.
5. MOORE KW, O'GARRA A, DE WAAL MALEFYT R, VIEIRA P, MOSMANN TR. Interleukin-10. Annu Rev Immunol 1993: 11: 165.
6. BLAY JY, BURDIN N, ROUSSET F, LENOIR G, BIRON P, PHILIP T, BANCHEREAU J, FAVROT MC. Serum interleukin-10 in non-Hodgkin's lymphoma: a prognostic factor. Blood 1993: 82: 2169.
7. EMILIE D, TOUITOU R, RAPHAEL M, PEUCHMAUR M, DEVERGNE O, REA D, COUMBRARAS J, CREVON MC, EDELMAN L, JOAB I, GALANAUD P. In vivo production of interleukin-10 by malignant cells in AIDS lymphomas. Eur J Immunol 1992: 22: 2937.
8. HERBST H, FOSS HD, SAMOL J. ARAUJO I, KLOTZBACH H, KRAUSE H, AGATHANGGELOU A, NIEDOBITEK G, STEIN H. Frequent expression of interleukin-10 by Epstein-Barr virus-harboring tumor cells of Hodgkin's disease. Blood 1996: 87: 2918.
9. STARLZ TE, NALESNIK MA, PORTER KA, IWATSUKI S, ROSENTHAL JT, SHAW BW JR. NALESNIK MA, HO M, GRIFFITH BP, HAKALA TR, HARDESTY RL, JAFFE R. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet 1984: i: 583.
10. TOSATO G, JONES K, BREINIG MK, MCWILLIAMS HP, MCKNIGHT JLC. Interleukin-6 production in post-transplant lymphoproliferative disease. J Clin Invest 1993: 91: 2806.
11. BURDIN N, PÉRONNE C, BANCHEREAU J, ROUSSET F. Epstein-Barr virus transformation induces B lymphocytes to produce human interleukin 10. J Exp Med 1993: 177: 295.
12. DESCAMPS-LATSCHA B, HERBELIN A. Long-term dialysis and cellular immunity: a critical survey. Kidney Intern 1993: 43: S135.
13. URENA P, HERBELIN A, ZINGRAFF J, LAIR M, MAN K, DESCAMPS-LATSCHA B, DRÜEKE T. Permeability of cellulosic and non-cellulosic membranes to endotoxin subunits and cytokine production during in-vitro haemodialysis. Nephrol Dial Transplant 1992: 7: 16.
14. CHIU PJS, RADWANSKI E, TETILOFF G, MONGE A, SWANSON SJ. Interleukin-10 pharmacokinetics in intact and nephrectomized mice. Eur Cytokine Netw 1996: 7: 67.
15. BACCHETTA R, BIGLER M, TOURAINE JL, TOVO PA, ABRAMS J, DE WAAL MALEFYT R, DE VRIES JE, RONCAROLO MG. High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA-mismatched hematopoietic stem cells. J Exp Med 1994: 179: 493.
16. GARNIER JL, LEBRANCHU Y, DANTAL J, BEDROSSIAN J, CAHEN R, ASSOULINE D, JACCARD A, FÉTISSOF F, MOREAU A, MARTIN X, DELSOL G, BERGER F, TOURAINE JL. Hodgkin's disease after transplantation. Transplantation 1996: 61: 71.
17. BAIOCCHI RA, ROSS ME, TAN JC, CHOU CC, SULLIVAN L, HALDAR S, MONNE M, SEIDEN M, NARULA SK, SKLAR J, CROCE CM, CALIGIURI MA. Lymphomagenesis in the SCID-hu mouse involves abundant production of human interleukin-10. Blood 1995: 85: 1063.
18. RICKINSON AB, MOSS DJ. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Annu Rev Immunol 1997: 15: 405.
19. CHERNOFF AE, GRANOWITZ EV, SHAPIRO L, VANNIER E, LONNEMAN G, ANGEL JB, KENNEDY JS, RABSON AR, WOLFF SM, DINARELLO CA. A randomized, controlled trial of IL-10 in humans. J Immunol 1995: 154: 5492.
20. ROONEY CM, SMITH CA, NG CYC, LOFTIN S, LI C, KRANCE RA, BRENNER MK, HESLOP HE. Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet 1995: 345: 9.
21. FISHER A, BLANCHE S, LE BIDOIS J, BORDIGONI P, GARNIER JL, NIAUDET P, MORINET F, LE DEIST F, FISCHER AM, GRISCELLI C, HIRN C. Anti-B cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone-marrow and organ transplantation. N Engl J Med 1991: 324: 1451.